Boca Raton Regional Hospital First in South Florida to Offer New Innovation in Endoscopic Biopsies
Boca Raton Regional Hospital’s Stephen Steinberg, MD, is now performing biopsies on at-risk patients during standard endoscopy procedures to view internal tissues at the microscopic level instantaneously. Boca Regional was the first in South Florida and is the only hospital in Palm Beach County to offer Cellvizio ® to patients, which revolutionizes the diagnosis and treatment of certain cancers.
Cellvizio, the smallest, flexible microscope in the world, is an optical biopsy technology that enables tissue within the human body to be viewed directly at the cellular level. It allows for the detection of anomalies that are invisible to the naked eye in various different organs, particularly in the gastrointestinal, urinary and pulmonary systems. To utilize Cellvizio, Dr. Steinberg threads the tiny microscope through a traditional endoscope.
The detailed cellular look appears in real time on the screen under the administration of a contrast agent, allowing the physician to recognize typical features of healthy and diseased tissue. “With Cellvizio, we have a tool that provides microscopic images of the lining of the gastrointestinal tract and pulmonary tissue,” said Dr. Steinberg, Medical Director of the Pancreas & Biliary Center of South Florida at the Eugene M. & Christine E. Lynn Cancer Institute at Boca Regional. “This enables us to determine whether the tissue is benign or malignant, and helps us to guide treatment decisions in real-time. We now have more visual information about internal tissues than ever before.”
Until now, areas that appeared abnormal during endoscopic procedures would be biopsied and sent to a laboratory for analysis. With Cellvizio the process is more precise, increasingly efficient and can accelerate the diagnostic and treatment process.
The Cellvizio technology provides the opportunity to avoid complicated interventions, including eliminating a number of additional invasive procedures. It is also possible to direct patients more quickly towards the appropriate treatment. Boca Regional is only one of approximately 100 centers in the United States using Cellvizio. Cellvizio is cleared by the U.S. Food and Drug Administration (FDA) for use in the gastrointestinal tract and lungs.